Cavernous sinus thrombosis medical therapy

Jump to navigation Jump to search

Cavernous sinus thrombosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cavernous sinus thrombosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cavernous sinus thrombosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cavernous sinus thrombosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cavernous sinus thrombosis medical therapy

CDC on Cavernous sinus thrombosis medical therapy

Cavernous sinus thrombosis medical therapy in the news

Blogs on Cavernous sinus thrombosis medical therapy

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Cavernous sinus thrombosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Medical Therapy

  • Antithrombotics
    • Anticoagulation
    • Standard treatment at this time, even if moderate intracranial hemorrhage present
    • Controversial in the past given risk of associated hemorrhage – one small randomized study with 20 patients in each arm showed a significant benefit making anticoagulation standard of care.
    • Thrombolysis – with agents like urokinase, TPA – generally given via microcatheters inserted for local infusion
    • Initial infusion sometimes followed by continuous infusion for a day or more until clot clears.
    • Many case reports of success, but not standard treatment at this time.
    • A study of 9 patients in Korea showed successful thrombolysis in all patients
    • Risk of hemorrhage
    • The literature suggests that it is mostly used now in severe cases with stupor, coma, rapidly progressing course, or severely raised ICP, and only in centers experienced in the methodology. Its role may expand with more experience.
    • Surgical thrombectomy – not generally performed anymore
  • Antieleptics – as indicated
  • Antibiotics – if infectious precipitant
  • Intracranial pressure manipulation

References


Template:WS